Boxcani 3.5 mg Injection 1's Substitute

Boxcani 3.5 mg Injection 1's contains the active substance bortezomib, also-called ‘proteasome inhibitor. Proteasomes play an important role in controlling cell function and growth. By interfering with their function, thereby it can kill cancer cells.

Boxcani 3.5 mg Injection 1's is prescribed by a doctor experienced in the use of medications to treat cancer. It is administered by a healthcare professional as an injection into your vein (intravenously or IV) or under your skin (subcutaneously, or SC). Boxcani 3.5 mg Injection 1's must not be administered into your spinal fluid (intrathecally).

Yes, Boxcani 3.5 mg Injection 1's can cause low neutrophils levels, a type of white blood cells that help fight infections. If your white blood cells become low, you can be at higher risk for infections. Tell your doctor if you develop a fever or believe you have an infection.

Avoid taking Boxcani 3.5 mg Injection 1's if you are pregnant because Boxcani 3.5 mg Injection 1's can cause harmful effects on the unborn baby. Females should follow effective birth control methods during treatment and at least six months after the final dose of Boxcani 3.5 mg Injection 1's.

Before you receive treatment with Boxcani 3.5 mg Injection 1's, tell your doctor about all of your medical conditions. You should not receive Boxcani 3.5 mg Injection 1's if you are allergic to bortezomib or any contents in Boxcani 3.5 mg Injection 1's.